A crucial aspect of regenerative healthcare and drug discovery lies in the ability to grow human stem cell groups to sufficient amounts for therapeutic applications. Traditionally, restricted cell supply posed a significant barrier to progress in these fields. Consequently, considerable work has been directed towards improving protocols for stem ce